NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
Clinical trials for NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-shot CAR-T therapy takes on stem cell transplant for multiple myeloma
⭐️ CURE ⭐️ Not yet recruitingThis phase 3 trial tests whether a single infusion of AZD0120, a CAR-T cell therapy that targets two proteins on myeloma cells, can outperform the standard approach of high-dose chemotherapy followed by a stem cell transplant. The study enrolls adults newly diagnosed with multipl…
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: ⭐️ CURE ⭐️
Last updated Aug 01, 2026 00:00 UTC
-
New hope for myeloma: experimental drug combo aims to beat standard care
Disease control Not yet recruitingThis phase 2 trial compares two drug combinations for people newly diagnosed with multiple myeloma who are not eligible for or have deferred a stem cell transplant. One group gets the experimental drug elranatamab plus standard medications (lenalidomide, bortezomib, dexamethasone…
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC